Therefore, we analyzed ROS in our murine model of human AML using flow cytometry and were able to show that GFI1-36N leukemic cells displayed significantly increased ROS levels compared to GFI1-36S-MLL-AF9 cells (Figure 2A and Figure S2A). This evidence concerns the gene KMT2A and acute myeloid leukemia.